Does SIMVASTATIN Cause Cholangiocarcinoma? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Cholangiocarcinoma have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.0% of all adverse event reports for SIMVASTATIN.
12
Reports of Cholangiocarcinoma with SIMVASTATIN
0.0%
of all SIMVASTATIN reports
2
Deaths
11
Hospitalizations
How Dangerous Is Cholangiocarcinoma From SIMVASTATIN?
Of the 12 reports, 2 (16.7%) resulted in death, 11 (91.7%) required hospitalization.
Is Cholangiocarcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Cholangiocarcinoma?
RANITIDINE (100)
ADALIMUMAB (62)
TACROLIMUS (56)
METHOTREXATE (55)
INFLIXIMAB (54)
LENALIDOMIDE (49)
PREDNISONE (48)
MYCOPHENOLATE MOFETIL (45)
PEMIGATINIB (44)
CYCLOPHOSPHAMIDE (42)
Which SIMVASTATIN Alternatives Have Lower Cholangiocarcinoma Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS